Feel Therapeutics is the Digital Precision Medicine company for mental and behavioral health. We translate passive monitoring data into insights and enable precise interventions.

While objective measurement tools have been leveraged in almost every medical field for centuries, the field of mental health lags behind, representing a significant shortfall in the effective diagnosis, management, and care of mental health. Feel is driven by the vision of a world where mental health treatment is as precise and personalized as possible, ensuring the right care/intervention for each individual at the right time.

Central to Feel Therapeutics is our proprietary Digital Precision Medicine Platform. This platform translates a variety of complex and heterogeneous data into significant insights, offering a holistic perspective on a patient's mental health for researchers and providers, and facilitating real-time, individualized support and interventions. These interventions are grounded in a profound comprehension of each person's unique mental health requirements, and can be used as a standalone digital therapy or in conjunction with medicine as a part of Feel’s Drug+ solution, improving patient outcomes and adherence.

Feel’s dedication to utilizing continuous passive data monitoring has consistently demonstrated effectiveness in enhancing outcomes across various mental health conditions, with results validated in several published studies.

Headquartered in San Francisco, with additional offices in Europe, Feel Therapeutics is backed by top-tier investors and works in partnership with leading Pharmaceutical companies and CROs.

For more information about our work in mental health care, visit www.feeltherapeutics.com.